Patrick Machado, 10% Owner at Urovant Sciences Ltd. (UROV), bought 6,541 shares at $8.53 ($56K) on 2019-06-17, disclosed to the SEC on 2019-06-19.
Open-market purchase of $56k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| UROV | BUY | 2019-06-19 | $55K | — | Filing → |
| UROV | BUY | 2019-06-19 | $303K | — | Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |